Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

FDA lifts partial clinical hold on Mersana’s Phase l study of XMT-1522

Tumour spheroid. Credit: OSA Student Chapter at UCI Art in Science Contest.

Go Top